Akoya Biosciences, Inc.
US ˙ NasdaqGS ˙ US00974H1041
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAKYA / Akoya Biosciences, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership9,458 shares
Latest Disclosed Value $ 12,295
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 75.15% decrease in ownership of AKYA / Akoya Biosciences, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 9,458 shares of Akoya Biosciences, Inc. (US:AKYA) valued at $12,295 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 38,057 shares of Akoya Biosciences, Inc.. This represents a change in shares of -75.15% during the quarter. The current value of the position is $12,201 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Akoya Biosciences EC US00974H1041 9,458 -28,599 -75.15 12 -76.92 0.0003
2025-05-28 2025-03-31 NP Akoya Biosciences EC US00974H1041 38,057 0 0.00 53 -40.23 0.0013
2025-02-25 2024-12-31 NP Akoya Biosciences EC US00974H1041 38,057 -25,264 -39.90 87 -49.42 0.0019
2024-11-26 2024-09-30 NP Akoya Biosciences EC US00974H1041 63,321 22,665 55.75 172 81.05 0.0033
2024-08-26 2024-06-30 NP Akoya Biosciences EC US00974H1041 40,656 0 0.00 95 -50.00 0.0019
2024-05-28 2024-03-31 NP Akoya Biosciences EC US00974H1041 40,656 0 0.00 191 -4.04 0.0040
2024-02-26 2023-12-31 NP Akoya Biosciences EC US00974H1041 40,656 0 0.00 198 4.76 0.0042
2023-11-28 2023-09-30 NP Akoya Biosciences EC US00974H1041 40,656 8,015 24.56 189 -21.58 0.0049
2023-08-25 2023-06-30 NP Akoya Biosciences EC US00974H1041 32,641 7,232 28.46 241 16.43 0.0057
2023-05-26 2023-03-31 NP Akoya Biosciences EC US00974H1041 25,409 0 0.00 208 -14.81 0.0055
2023-02-24 2022-12-31 NP Akoya Biosciences EC US00974H1041 25,409 0 0.00 243 -18.46 0.0067
2022-11-25 2022-09-30 NP Akoya Biosciences EC US00974H1041 25,409 2,774 12.26 299 2.76 0.0086
2022-08-25 2022-06-30 NP Akoya Biosciences EC US00974H1041 22,635 0 0.00 291 16.94 0.0080
2022-05-26 2022-03-31 NP Akoya Biosciences EC US00974H1041 22,635 0 0.00 249 -28.32 0.0058
2022-02-25 2021-12-31 NP Akoya Biosciences EC US00974H1041 22,635 10,448 85.73 347 103.53 0.0075
2021-11-24 2021-09-30 NP Akoya Biosciences EC US00974H1041 12,187 0 0.00 170 -27.66 0.0037
2021-08-26 2021-06-30 NP Akoya Biosciences EC US00974H1041 12,187 12,187 236 0.0051
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.